Skip to main content
Clinical Trials/ISRCTN23197625
ISRCTN23197625
Completed
N/A

The effects of reducing worry in patients with persecutory delusions: An explanatory randomised controlled trial

The Efficacy and Mechanism Evaluation Programme (MRC/NIHR) (UK)0 sites150 target enrollmentApril 20, 2011

Overview

Phase
N/A
Intervention
Not specified
Conditions
Persecutory delusions in the context of schizophrenia or related diagnosis
Sponsor
The Efficacy and Mechanism Evaluation Programme (MRC/NIHR) (UK)
Enrollment
150
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 20, 2011
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
The Efficacy and Mechanism Evaluation Programme (MRC/NIHR) (UK)

Eligibility Criteria

Inclusion Criteria

  • 1\. A current persecutory delusion as defined by Freeman and Garety (2000\); scoring at least 3 on the conviction scale of the PSYRATS (Haddock et al, 1999\)
  • 2\. That the delusion has persisted for at least one month
  • 3\. A clinical diagnosis of schizophrenia, schizoaffective disorder or delusional disorder (i.e. diagnosis of non\-affective psychosis (F2\) in the International Classification of Diseases and Diagnostic and Statistical Manual IV)
  • 4\. A clinically significant level of worry, as indicated by scores above 44 on the Penn State Worry Questionnaire (see Startup and Erickson, 2006\)
  • 5\. Aged between 18 and 65
  • 6\. Where major changes in medication are being made, entry to the study would not occur until at least a month after stabilisation of dosage

Exclusion Criteria

  • 1\. A primary diagnosis of alcohol or substance dependency
  • 2\. Organic syndrome or learning disability
  • 3\. A command of spoken English inadequate for engaging in therapy
  • 4\. Currently having individual cognitive behavioural therapy (CBT) (though previous CBT experience is not an exclusion)

Outcomes

Primary Outcomes

Not specified

Similar Trials